ation has contributed to the popularity of several other therapeutic methods.2 Depending on a number of clinical factors, current options to enucleation for uveal melanoma include a period of observation without interventional treatment, plaque radiotherapy, charged particle irradiation, trans-scleral lamellar resection, laser photocoagulation, and transpupillary thermotherapy. In The second paper by Damato and associates (p 109) describes the risk factors for metastatic uveal melanoma after trans-scleral local resection. As acknowledged by the authors, it is not surprising that advanced age, more malignant cell type, and greater tumour diameter were significantly associated with eventual metastasis. The association of superior location of the tumour with eventual metastasis is curious and difficult to explain. It is of interest that lack of adjunctive plaque radiotherapy was also associated with increased chance of metastasis. This again supports the argument for considering combined treatments in the initial therapeutic plan.
Since removal of posterior uveal tumours by local resection is a difficult and time consuming procedure which requires more complicated postoperative care, one may question the advisability of local resection in cases where there is little hope for any useful vision in the affected eye. Although in these latest papers the authors do not elaborate on their current indications for trans-scleral resection, the data that they present in these and earlier publications may provide insight as to when this procedure should be employed. This information would be of value to physicians who may employ local resection or who may wish to refer patients for that procedure. Based on their results and our personal experience, I would like to describe briefly what we believe to be the current relative indications and contraindications for local resection of ciliary body and choroidal melanoma. It is stressed that this represents a personal viewpoint which may differ somewhat from that of Damato and associates and other clinicians who may use local resection of posterior uveal melanoma.
The indications for local resection will necessarily vary from patient to patient and each case must be individualised depending on the entire clinical situation. However, in general, local resection should be considered when the patient is middle aged or younger, and when the tumour has a more anterior location, greater thickness, smaller base, and is located on the nasal side of the eye. Tumours located near the optic disc and foveola, those with lesser thickness, larger base, and located on the temporal side are likely to be associated with considerable visual impairment following local resection and, in such cases, other methods such as radiotherapy or enucleation should be considered. Younger individuals tend to tolerate better the hypotensive anaesthesia and have less vascular disease that might contribute to intraoperative or postoperative bleeding. Furthermore, the gelatinous vitreous in younger patients provides better retinal tamponade. Tumours with greater basal diameter and less thickness are best treated with radioactive plaques, perhaps combined with laser or thermotherapy.
When the patient is older, has systemic vascular disease, is taking systemic anticoagulants or when the tumour has a larger base, less thickness, and is more posteriorly located, it may be more advisable to recommend plaque radiotherapy or enucleation. Local resection in such cases is more difficult and more likely to result in intraoperative and postoperative complications such as vitreous haemorrhage, subretinal haemorrhage, retinal detachment, and severe visual impairment. In addition, the reports of Damato and associates suggest that local recurrence and systemic metastasis may be greater in such cases.
More specifically, we believe that local resection can be favoured when the patient is less than 65 years of age and in good health; the tumour thickness is greater than 8 mm, its diameter is less than 15 mm, its posterior margin is more than 4 mm from the foveola and 3 mm from the optic disc, and has a nasal location. We believe that local resection is relatively contraindicated for patients older than 65 years, when the tumour is less than 8 mm in thickness, more than 15 mm in diameter, less than 4 mm from the foveola and 3 mm from the optic disc, and has a temporal location. Most such tumours are best treated with plaque radiotherapy, thermotherapy, or a combination of those two methods.
It is quite certain that most posterior uveal melanomas will continue to be managed by radiotherapy or enucleation and that local resection will be reserved for cases that meet the relatively strict criteria outlined above. However, we believe currently that local resection has a definite place in the management of selected posterior uveal melanomas and that there are frequent instances where it is clearly the treatment of choice. However, the surgery is very difficult and there are numerous potential complications. Therefore, this procedure should only be performed at institutions where there are experienced surgeons who have the frequent opportunities to perform such surgery. It is quite likely that more patients undergoing local resection for uveal melanoma will receive supplemental treatment with radiotherapy, photocoagulation, thermotherapy, or other adjunctive measures in the future. Foulds and Damato have pioneered the development and perfection of local resection of uveal melanoma and they are to be congratulated for their continued contributions. 
